Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study
- PMID: 18987105
- DOI: 10.1177/1352458508098562
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study
Abstract
Objective: The purpose of the study was to compare and contrast the initial presenting demographic, clinical, neuroimaging, and laboratory features in a cohort of children affected from multiple sclerosis (MS) or acute disseminated encephalomyelitis (ADEM).
Methods: A 12-year prospective study was conducted in 68 pediatric patients (age<or=17 years) who presented with a first episode of central nervous system inflammation suggestive of a demyelinating multifocal pathology. All patients had undergone magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) examination. The mean follow-up period, as at ending on December 31, 2007, was 6.8+/-2.7 years (range 3.2-12.6 years).
Results: At clinical onset, children who developed MS during the follow-up (48 patients; 34 females, 14 males; mean age at onset: 14.4+/-2.5) significantly differed from children affected by ADEM (20 patients; 8 females, 12 males; mean age at onset: 8.1+/-3.8) for the following parameters: prevalence of females affected (female/male ratio: 2.8 versus 0.6, P=0.03); mean age at onset (P<0.001); monosymptomatic onset (73% vs 30%, P=0.002); encephalopathy-like onset (0% vs 50%, P<0.001); presence of oligoclonal IgG bands (IgGOB) in CSF (83% vs 10%, P<0.001); and periventricular (79% vs 20%, P<0.001), brain stem (12.5% vs 60%, P=0.000), and basal ganglia (10% vs 50%, P<0.001) lesions at MRI.
Conclusions: Our findings depict a pattern of demographic, clinical, neuroimaging, and laboratory findings that can help to distinguish, at clinical onset, children suffering from ADEM from those who will develop MS. Childhood-onset MS seems not to differ from adult-onset MS from both clinical and paraclinical features.
Similar articles
-
Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.Dev Med Child Neurol. 2007 Dec;49(12):887-93. doi: 10.1111/j.1469-8749.2007.00887.x. Dev Med Child Neurol. 2007. PMID: 18039234
-
Acute disseminated encephalomyelitis in children: one medical center experience.Acta Paediatr Taiwan. 2006 Mar-Apr;47(2):67-71. Acta Paediatr Taiwan. 2006. PMID: 16927630
-
Role of MRI in the differentiation of ADEM from MS in children.Neurology. 2009 Mar 17;72(11):968-73. doi: 10.1212/01.wnl.0000338630.20412.45. Epub 2008 Nov 26. Neurology. 2009. PMID: 19038851
-
[Multiple sclerosis in children: clarifying its place among the demyelinating spectrum].Invest Clin. 2006 Dec;47(4):413-25. Invest Clin. 2006. PMID: 17176909 Review. Spanish.
-
Acute disseminated encephalomyelitis.Neurology. 2007 Apr 17;68(16 Suppl 2):S23-36. doi: 10.1212/01.wnl.0000259404.51352.7f. Neurology. 2007. PMID: 17438235 Review.
Cited by
-
Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in Children: Experience in a Tertiary Center, Upper Egypt.Electron Physician. 2016 Jul 25;8(7):2679-85. doi: 10.19082/2679. eCollection 2016 Jul. Electron Physician. 2016. PMID: 27648197 Free PMC article.
-
Epidemiological, Clinical, and Laboratory Characteristics of Acute Disseminated Encephalomyelitis in Children: A Retrospective Study.Iran J Child Neurol. 2019 Fall;13(4):65-73. Iran J Child Neurol. 2019. PMID: 31645867 Free PMC article.
-
Younger children with MS have a distinct CSF inflammatory profile at disease onset.Neurology. 2010 Feb 2;74(5):399-405. doi: 10.1212/WNL.0b013e3181ce5db0. Neurology. 2010. PMID: 20124205 Free PMC article.
-
Evaluation of inflammatory acquired demyelinating syndromes in children: a single-center experience.Acta Neurol Belg. 2022 Dec;122(6):1485-1491. doi: 10.1007/s13760-021-01703-4. Epub 2021 May 10. Acta Neurol Belg. 2022. PMID: 33973168
-
Treatment of acute disseminated encephalomyelitis.Curr Treat Options Neurol. 2012 Jun;14(3):264-75. doi: 10.1007/s11940-012-0170-0. Curr Treat Options Neurol. 2012. PMID: 22476745
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical